CoChat

Scale‐Down Model Development in ambr systems: An Industrial Perspective

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

High‐Throughput (HT) technologies such as miniature bioreactors (MBRs) are increasingly employed within the biopharmaceutical manufacturing industry. Traditionally, these technologies have been utilized for discrete screening approaches during pre‐clinical development (e.g., cell line selection and process optimization). However, increasing interest is focused towards their use during late clinical phase process characterization studies as a scale‐down model (SDM) of the cGMP manufacturing process. In this review, the authors describe a systematic approach toward SDM development in one of the most widely adopted MBRs, the ambr 15 and 250 mL (Sartorius Stedim Biotech) systems. Recent efforts have shown promise in qualifying ambr systems as SDMs to support more efficient, robust and safe biomanufacturing processes. The authors suggest that combinatorial improvements in process understanding (matching of mass transfer and cellular stress between scales through computational fluid dynamics and in vitro analysis), experimental design (advanced risk assessment and statistical design of experiments), and data analysis (combining uni‐ and multi‐variate techniques) will ultimately yield ambr SDMs applicable for future regulatory submissions.

Overview

Integrity signals

Registry

Crossref · 10.1002/biot.201700766

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Research works printed but not linked: 9

  1. Banerjee A., 2010, BioPharm Int, 23, 26
  2. Chen A., 2009, Biotechnol. Bioeng, 102, 48
  3. Marks D. M., 2003, Cytotechnology, 103, 733
  4. de Wilde D., 2014, BioProcess Int
  5. Shivhare M., 2010, BioProcess Int, 8, 22
  6. McCreath G., 2011, EBR, 62
  7. DeCesare C., 2016, Bioprocess Int, 14, 18
  8. Spann R., 2018, Ref. Mod. Chem. Mol. Sci. Chem. Eng, 1
  9. Anane E., 2018, J. Chem. Technol. Biotechnol, 0268

Cited by

See all 72

Metadata

Authors
Sandner, V., Pybus, L. P., McCreath, G., & Glassey, J.
Affiliations
  • Fujifilm (United Kingdom) (GB)
  • Newcastle University (GB)
Corresponding author
Sandner, Viktor
Venue
Biotechnology Journal
Publisher
Wiley
Published
2018-11-26
Volume
14
Issue
4
Pages
e1700766-e1700766
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2895809414
Cited by
63
References
60
Citations by year
2026: 8 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 5
FWCI
0.45
Type
journal article
Language
en
Open access
Locations
  • Biotechnology Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
H2020 Marie Skłodowska-Curie Actions (643056)
Topics
  • Physical Sciences › Chemical Engineering › Fluid Flow and Transfer Processes › Fluid Dynamics and Mixing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
scale-down model, biopharmaceutical manufacturing, process characterization, cGMP production, mass transfer, cellular stress, computational fluid dynamics, experimental design, risk assessment, multivariate analysis, regulatory submissions
MeSH terms
Animals, Cricetulus, Cyclic GMP, Cricetinae, Industry, CHO Cells, Bioreactors, High-Throughput Screening Assays, Hydrodynamics, Batch Cell Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Scale‐Down Model Development in ambr systems: An Industrial Perspective. https://app.cochat.ai/papers/10.1002/biot.201700766
The paper
Sandner, V., Pybus, L. P., McCreath, G., & Glassey, J. (2019). Scale‐Down Model Development in ambr systems: An Industrial Perspective. Biotechnology Journal. https://doi.org/10.1002/biot.201700766

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.